Explore more publications!

Press Releases

Zymeworks and Royalty Pharma Enter into $250 Million Royalty-Backed Note Financing
Royalty Pharma and Zymeworks Enter Into $250 Million Royalty-Backed Note Financing
NovaBridge to Present at the Leerink Partners 2026 Global Healthcare Conference
Eton Pharmaceuticals Expands Rare Disease Portfolio Through Acquisition of U.S. Commercialization Rights to HEMANGEOL® (propranolol hydrochloride) Oral Solution
NRx Pharmaceuticals (Nasdaq: NRXP) Appoints Prof. Joshua Brown MD, PhD, as Chief Medical Innovation Officer
Royalty Pharma Appoints Kenneth Sun as Senior Vice President and Head of Asia to Expand Royalty Pharma's Global Platform
NP Unveils ‘MUA’H’ at MWC 2026: An AI-Powered Sanctuary for Workplace Mental Health
Asbestos fees drive inspections strengthening public health protections

Asbestos fees drive inspections strengthening public health protections

Los Angeles Addiction Crisis Highlights Need for Medically Supervised Detox and Residential Treatment
Intrinseque Health Spreads Festive Cheer to Underprivileged Students in Melaka
The Ultimate Sourcing Guide: Selecting a Cinnamon Bark Extract Manufacturer for Health Products
AGILON CLASS ACTION DEADLINE MARCH 2nd: Bragar Eagel & Squire, P.C. Urgently Reminds Agilon Health Investors with Large Losses to Contact the Firm Before the Lead Plaintiff Deadline
Lamentis Software Pvt. Ltd. Launches Exclusive 50% Marketing Budget Offer for U.S. Home Services & Healthcare Companies
CAPHRA Reminds Governments that Harm Reduction is the Foundation of Health Policy
Rhythm Pharmaceuticals Announces Additional Positive Data from Phase 3 TRANSCEND trial of Setmelanotide in Patients with Acquired Hypothalamic Obesity
Bronstein, Gewirtz & Grossman LLC Urges Ultragenyx Pharmaceutical Inc. Investors to Act: Class Action Filed Alleging Investor Harm
Bronstein, Gewirtz & Grossman LLC Urges Ardent Health, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
ARDT Deadline: BFA Law Urges Ardent Health Investors with Losses to Act Before March 9 Securities Fraud Class Action Deadline Amid 33% Stock Decline
WriteUpp Automated Reminders and Smart Booking Tools Drive Double-Digit Reductions in Healthcare No Show Rates
ROSEN, A LEADING NATIONAL FIRM, Encourages Picard Medical, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – PMI

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions